METHOD TO IDENTIFY PATIENTS WHO WOULD RESPOND FAVOURABLY TO HYPOLIPIDEMIC TREATMENT

摘要

The invention relates to a method that, using nutrigenetic models, allows the identification of adults with obesity and dyslipidaemia who will respond favourably to hypolipidemic treatment. The method protected by the invention is to be used in the medical/pharmaceutical field; the method involves the calculation of a genetic risk score for adults with obesity and dyslipidaemia, a score that indicates the probability that they will respond favourably to hypolipidemic treatment. The problem solved by the invention is to identify those individuals for whom the usual / classic hypolipidemic treatment will have the expected outcome, so that such treatment will be administrated to them. It is known that the usual / classic hypolipidemic treatment has adverse effects on the patients, so that the invention would reduce both the negative consequences on the health of the patients and the financial burden of the patient, health system and society in general.